Fujiwara K - Search Results

1

Fulminant hepatic failure associated with triazolam.

Kanda T, Yokosuka O, Fujiwara K, Saisho H, Shiga H, Oda S, Okuda K, Sugawara Y, Makuuchi M, Hirasawa H. Kanda T, et al. Among authors: fujiwara k. Dig Dis Sci. 2002 May;47(5):1111-4. doi: 10.1023/a:1015054510949. Dig Dis Sci. 2002. PMID: 12018909 No abstract available.

2

Fulminant hepatic failure associated with benzbromarone treatment: a case report.

Arai M, Yokosuka O, Fujiwara K, Kojima H, Kanda T, Hirasawa H, Saisho H. Arai M, et al. Among authors: fujiwara k. J Gastroenterol Hepatol. 2002 May;17(5):625-6. doi: 10.1046/j.1440-1746.2002.02692.x. J Gastroenterol Hepatol. 2002. PMID: 12084041 No abstract available.

3

Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities.

Fujiwara K, Yokosuka O, Imazeki F, Saisho H, Saotome N, Suzuki K, Okita K, Tanaka E, Omata M. Fujiwara K, et al. Hepatol Res. 2003 Feb;25(2):124-134. doi: 10.1016/s1386-6346(02)00245-0. Hepatol Res. 2003. PMID: 12644048

4

[Association between severity of hepatitis A and variations of hepatitis A virus genome].

Fujiwara K, Yokosuka O. Fujiwara K, et al. Nihon Rinsho. 2003 Mar;61 Suppl 3:615-20. Nihon Rinsho. 2003. PMID: 12718037 Review. Japanese. No abstract available.

5

[Hepatitis A virus genotypes].

Fujiwara K, Yokosuka O. Fujiwara K, et al. Nihon Rinsho. 2004 Aug;62 Suppl 8:433-7. Nihon Rinsho. 2004. PMID: 15453361 Review. Japanese. No abstract available.

6

[Association between severity of hepatitis A and variations in hepatitis A viral RNA].

Fujiwara K, Yokosuka O. Fujiwara K, et al. Nihon Rinsho. 2004 Aug;62 Suppl 8:458-61. Nihon Rinsho. 2004. PMID: 15453365 Review. Japanese. No abstract available.

7

Do high levels of viral replication contribute to fulminant hepatitis A?

Fujiwara K, Yokosuka O, Imazeki F, Saisho H, Miki M, Omata M. Fujiwara K, et al. Liver Int. 2005 Feb;25(1):194-5. doi: 10.1111/j.1478-3231.2004.0981.x. Liver Int. 2005. PMID: 15698418 No abstract available.

8

Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B.

Fujiwara K, Yokosuka O, Kojima H, Kanda T, Saisho H, Hirasawa H, Suzuki H. Fujiwara K, et al. World J Gastroenterol. 2005 Feb 28;11(8):1109-14. doi: 10.3748/wjg.v11.i8.1109. World J Gastroenterol. 2005. PMID: 15754390 Free PMC article. Clinical Trial.

9

Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.

Kanda T, Yokosuka O, Imazeki F, Fujiwara K, Nagao K, Saisho H. Kanda T, et al. Among authors: fujiwara k. Biochem Biophys Res Commun. 2005 Jun 3;331(2):621-9. doi: 10.1016/j.bbrc.2005.03.212. Biochem Biophys Res Commun. 2005. PMID: 15850805

10

[Diagnostic tests: Serum anti-hepatitis A virus antibody and hepatitis A virus RNA].

Fujiwara K, Yokosuka O. Fujiwara K, et al. Nihon Rinsho. 2005 Jul;63 Suppl 7:401-3. Nihon Rinsho. 2005. PMID: 16111285 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,521 results

Search Page

Filters